R

RemeGen
9995

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
HK$26.89B
EV
HK$28.92B
Shares Outstanding
536.56M
Beta
0.37

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
HK$24.87
P/E 2025E
-
P/Revenue 2025E
10.64x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About RemeGen Co., Ltd.

gainify

R

RemeGen Co., Ltd.

9995

RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company o...

Sector

Healthcare

Industry

Biotechnology

CEO

Fang, Jianmin

Employees

2,999

IPO Date

2020-11-09

Headquarters

58 Middle Beijing Road, Yantai Development Zone, Yantai Area of Shandong Pilot Free Trade, Yantai, Shandong Province China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved